A recent addition to the signal transduction pathways that can be modulated by nitric oxide (NO ⅐ ) 1 is apoptosis, with both pro-and antiapoptotic effects reported depending on both cell type and NO ⅐ concentration (reviewed in Refs. 1 and 2). Antiapoptotic effects are associated with low levels (10 nM to 1 M) of exposure from the activation of endogenous NO ⅐ synthases and slow release rates from NO ⅐ donors (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Specific molecular targets include inhibition of Bcl-2 cleavage (3), inactivation of caspases by S-nitrosation (4 -10) , and cGMP-mediated effects (11, 12) . However, exposure of cells to high NO ⅐ concentrations (Ͼ1 M) results in extensive inhibition of mitochondrial ATP synthesis (13) (14) (15) , and while apoptosis is inhibited, necrotic cell death results (16, 17) . This is consistent with the greater ATP dependence of apoptosis compared with necrosis (16, 17) . Under some conditions, such as inflammation or neurodegenerative diseases, NO ⅐ -dependent apoptosis has been observed (18 -24) . In this case, the hypothesis that NO ⅐ reacts with superoxide to form peroxynitrite (25) has been suggested as a mechanism leading to apoptotic cell death (22) (23) (24) . It is clear from these observations that a number of molecular mechanisms underlie the effects of NO ⅐ on apoptosis.
A site for NO ⅐ modulation of the apoptotic process that has received little attention is the controlled release of cytochrome c from mitochondria. This is important, since it is becoming increasingly apparent that mitochondria are important mediators of apoptosis (26 -29) , and is possibly related to recent evidence for a mitochondrial NO ⅐ synthase that would produce NO ⅐ within the organelle (30, 31). The release of cytochrome c and apoptosis-inducing factor from mitochondria leads to activation of caspases 9 and 3 (29) , and it was recently reported that caspase 3 can activate caspase 8, which can in turn trigger cytochrome c release (32) . These findings suggest an amplification role for mitochondria in apoptotic signaling and support the concept that the control of cytochrome c release from the mitochondrion is likely to impact the progression of apoptosis.
Mitochondrial cytochrome c release is regulated by the Bcl-2 family of proteins (33) , which are targeted at the mitochondrial permeability transition pore (PTP). This multisubunit protein complex includes the mitochondrial voltage-dependent anion channel, the adenine nucleotide translocase, and cyclophilin D (33, 34) . Consistent with the molecular composition of the PTP, mitochondrial cytochrome c release is triggered by PTP inducers (Ca 2ϩ , phosphate, oxidants) and inhibited by PTP inhibitors (cyclosporin A, bongkrekic acid, EGTA). Recently, it was demonstrated that reconstituted PTP components (voltage-dependent anion channel, adenine nucleotide translocase, cyclophilin D) can regulate cytochrome c release from liposomes (35) .
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to S-nitrosothiols or high concentrations of NO ⅐ (0.6 -10 M), and PTP opening was observed (36, 37) . It has been suggested that these effects were not mediated by NO ⅐ but by other reactive nitrogen species such as peroxynitrite (22) (23) (24) (25) 38) or by S-nitrosation of mitochondrial proteins (37) . In contrast, it was also suggested that NO ⅐ may inhibit PTP in a subpopulation of mitochondria, but the effects on cytochrome c release were not reported (36) . Two major sites of interaction of NO ⅐ with mitochondria in the submicromolar concentration range have been identified at complex III and the oxygen binding site of cytochrome c oxidase (13, 39) . Through inhibition of electron transport at these sites and a decrease in mitochondrial membrane potential, it has been observed that NO ⅐ stimulates mitochondrial Ca 2ϩ efflux (40) . In addition, inhibition of the putative mitochondrial NOS facilitates Ca 2ϩ accumulation, consistent with either NO ⅐ -dependent prevention of Ca 2ϩ uptake or enhanced release (31) . These observations are significant in the context of control of cytochrome c release, since the PTP is initiated by an increase in the intramitochondrial Ca 2ϩ concentration, and predict that NO ⅐ should inhibit PTP opening (34) .
From the current literature, it is evident that the effects of NO ⅐ per se, and of varying NO ⅐ concentrations at the level of the isolated mitochondrion, on PTP and cytochrome c release are uncertain. It was hypothesized that low rates of NO ⅐ formation could inhibit Ca 2ϩ accumulation and thus inhibit subsequent PTP opening and cytochrome c release from isolated mitochondria. This hypothesis was tested by exposing isolated rat liver mitochondria to NO ⅐ released from NONOate compounds at rates encompassing both the physiological and pathological ranges, and the effects on PTP opening and cytochrome c release were determined.
EXPERIMENTAL PROCEDURES

Animals and Materials-Male
Harlan Sprague-Dawley rats, 250 -300 g in weight, were handled in accordance with recommendations in Ref. 48 . Food and water were available ad libitum. All biochemicals were from Sigma except cyclosporin A and NONOate compounds (Alexis, San Diego CA), antibodies (Pharmingen, San Diego CA), and chemiluminescence reagents (Amersham Pharmacia Biotech). Stock solutions of NONOates were prepared in 10 mM NaOH and stored frozen. Their degradation, assayed spectrophotometrically at 251 nm, was not significant over the course of 1 week.
Isolation of Mitochondria-Liver mitochondria were isolated according to standard procedures (41) in buffer containing sucrose (250 mM), Tris (10 mM), and EGTA (2 mM), pH 7.4, at 4°C. The final centrifugation step and resuspension were performed in EGTA-free medium. Protein was determined using the Folin-phenol reagent (42) against a standard curve constructed using bovine serum albumin.
Mitochondrial PTP Assay-Mitochondrial PTP opening was assayed essentially as described by Packer and Murphy (38) . Opening of the PTP causes mitochondrial swelling that is conveniently assayed as a decrease in the light scattering (and thus absorbance) of a mitochondrial suspension. Absorbance at 540 nm was measured using a Gilford Response TM spectrophotometer with a 37°C thermostatic chamber. Mitochondria (1 mg of protein) were suspended in polystyrene cuvettes in 1 ml of buffer containing HEPES (40 mM), mannitol (195 mM), sucrose (25 mM), succinate (5 mM), and rotenone (1 M), pH 7.2. After a 2-min equilibration period, CaCl 2 (60 M) was added, and absorbance was monitored for 20 min.
NO ⅐ donors (1-5 l of stock) were added 20 s before mitochondria unless otherwise indicated. The addition of NO ⅐ donors in NaOH did not significantly alter the pH of the buffer, and 5 l NaOH alone had no effect on swelling (result not shown). Half-lives of NONOate compounds in the buffer system used in these experiments were as follows: DEA NONOate, 4.29 min; spermine NONOate, 202 min; DETA NONOate, 1600 min. These values differ from those published by the manufacturer and highlight the importance of determining decomposition characteristics of these compounds in each experimental system studied. Rates of NO ⅐ release were determined by calculation from half-lives and polarographically using an NO ⅐ electrode (WPI, Sarasota, FL), both methods yielding indistinguishable results. In the open cuvette system employed in these studies, a linear relationship was observed between the rate of NO ⅐ release and the steady state concentration achieved, such that 15 nM NO ⅐ /s equated to a steady state concentration of 1 M. Beyond 100 nM NO ⅐ /s, this relationship became nonlinear.
Measurement of Mitochondrial Cytochrome c Release-At various time points during swelling experiments, cyclosporin A (5 M) and EGTA (1 mM) were added to mitochondrial suspensions to prevent further swelling, and 900-l aliquots were centrifuged at 14,000 ϫ g for 15 min. Supernatants were snap-frozen (liquid N 2 ) and later analyzed by Western blotting. Samples were run on 15% SDS-polyacrylamide gels (43) and electroblotted to nitrocellulose membranes (44) . Cytochrome c was detected using a mouse anti-cytochrome c IgG (Pharmingen), followed by a horseradish peroxidase-linked secondary antibody and ECL detection (both from Amersham Pharmacia Biotech). Supernatant samples were also analyzed by MALDI-TOF mass spectrometry in the mass spectrometry core facility at the University of Alabama at Birmingham, following a 10-fold concentration step using Centricon TM filtration devices (Millipore Corp., Bedford MA; 3000 molecular weight cut-off). The mass spectrometer was calibrated using apomyoglobin. Cytochrome c was not detectable by spectrophotometric methods (reduced/oxidized A 550 ) in these supernatants but was detectable in samples only centrifuged for 3 min, highlighting the importance of complete centrifugation in such experiments to avoid artifacts from nonpelleted mitochondria.
Measurement of Mitochondrial Calcium Uptake-Mitochondria were incubated as for swelling experiments but at a lower protein concentration (0.25 mg/ml) and in the presence of the non-membrane-permeant Ca 2ϩ -sensitive dye Arsenazo III (100 M), which measures extramitochondrial Ca 2ϩ (38) . The difference in absorbance between 675 and 685 nm was measured using a Beckman DU700 diode array spectrophotometer. Optionally present were spermine NONOate (2.2 mM) or ruthenium red (10 M). Readings were taken every 1 s, and data were smoothed using a 4-s moving integration window.
Measurement of Mitochondrial Membrane Potential (⌬)-Mitochondria were incubated in the same buffer used for swelling experiments, in an open chamber fitted with an electrode sensitive to the lipophilic cation triphenylmethylphosphonium (TPMP ϩ ) (45) . Nigericin was present at 100 nM. Four TPMP ϩ additions (final concentration 4 M) were made to calibrate the electrode, followed by succinate (5 mM) to energize mitochondria and then FCCP to uncouple and correct for electrode drift. Membrane potential was calculated from the accumulation ratio of TPMP ϩ using the Nernst equation and a previously determined TPMP ϩ binding correction (45) . Readings were taken every 1 s, and data were smoothed using a 4-s moving integration window.
RESULTS
Fig . 1A shows the effects of a variety of NO ⅐ donors on the Ca 2ϩ -induced swelling of rat liver mitochondria. Swelling was inhibited by NO ⅐ and also by cyclosporin A and was completely abolished by omission of Ca 2ϩ from the incubation, indicating that the phenomenon being observed was indeed PTP opening. Fig. 1B shows a dose response of the PTP to the effects of NO ⅐ released from the 3 NONOates. The maximal inhibition of PTP by NO ⅐ was comparable with or greater than that achievable by cyclosporin A (Fig. 1A) . The NO ⅐ release rate that gave 50% inhibition of PTP was ϳ11 nM NO ⅐ /s, equating to a steady state concentration of ϳ0.7 M. Data from all three NO ⅐ donors when normalized for NO ⅐ release rate were indistinguishable, indicating that the effects were specific to NO ⅐ and not due to the parent compounds. Fig. 2A shows the effects of the NO ⅐ donor spermine NONOate on mitochondrial Ca 2ϩ uptake measured by the Arsenazo III method (38) . The addition of CaCl 2 to the incubation caused a rapid increase in the Ca 2ϩ signal that progressively decreased as the Ca 2ϩ was taken up by the mitochondria and was reversed by the uncoupler FCCP. This phenomenon was ruthenium red-sensitive, indicating Ca 2ϩ entry to the mitochondrial matrix via the Ca 2ϩ uniporter. The presence of spermine NONOate at a concentration that inhibits PTP opening also completely prevented Ca 2ϩ uptake. In a second series of experiments, the effects of NO ⅐ on ⌬ were determined using TPMP Fig. 2B shows that the presence of NO ⅐ prevented development of ⌬ upon the addition of succinate as substrate. These data support the hypothesis that NO ⅐ inhibits the PTP by preventing membrane potential-driven Ca 2ϩ accumulation. To establish that inhibition of PTP opening required the continuous generation of NO ⅐ , the effects of oxyhemoglobin (oxyHb) were examined. Fig. 3A shows that the addition of oxyHb to mitochondria incubated with Ca 2ϩ plus NO ⅐ results in a complete and immediate reversal of the NO ⅐ -dependent inhibition of PTP opening. Oxyhemoglobin alone had no effect on the PTP. In a further series of experiments, the ability of NO ⅐ to inhibit PTP triggered by oxidants was examined. Fig. 3B shows that the well characterized induction of the PTP by Ca 2ϩ plus tert-butyl hydroperoxide can also be inhibited by NO ⅐ . Similar results were obtained when Ca 2ϩ plus phosphate was used to induce PTP (not shown). plus cyclosporin-A (not shown). To examine the release of proteins from mitochondria that cannot be detected by Western blotting, concentrated supernatants were also analyzed by MALDI-TOF mass spectrometry. Fig. 4C shows typical mass spectra from the same postmitochondrial supernatants as in Fig. 4A . In agreement with the Western blot data, these spectra indicate that NO ⅐ inhibited cytochrome c release (12.1-kDa peak). The release of other proteins upon PTP opening (e.g. the peak at 10.8 kDa) was also inhibited by NO ⅐ . The amount of protein released from untreated mitochondria was very low, indicating minimal nonspecific leakage of proteins during the time course of these experiments.
In a cell system, complete inhibition of the PTP in all mitochondria within a cell could only occur if high concentrations of NO ⅐ were present. However, this could also result in inhibition of ATP synthesis and would ultimately be cytotoxic. In a cytoprotective role, a partial inhibition of the PTP by NO ⅐ is envisaged, but it is unclear whether this would significantly impact on cytochrome c release. This was examined in the next series of experiments. Fig. 5A shows the time course of cytochrome c release during Ca 2ϩ -induced PTP opening. Superimposed is the swelling profile for these mitochondria. It is immediately apparent that ϳ80% of cytochrome c is released within ϳ1 min of Ca 2ϩ addition and prior to the rapid phase of swelling. This suggests that cytochrome c release is an early event in Ca 2ϩ -induced PTP.
To further determine the effects of NO ⅐ on the relationship . NO ⅐ donors were present from the start of the incubation (ϳ20 s before mitochondria) as follows: DEA NONOate, 1.3 mM; DETA NONOate, 3.1 mM; spermine NONOate, 2.2 mM. CsA, cyclosporin A, 5 M. Data are means of at least three experiments. Error bars (S.E.) are omitted from all but control data for clarity. B, dose response of Ca 2ϩ -induced mitochondrial PTP to NO ⅐ . Mitochondria were incubated as described under "Experimental Procedures." Spermine NONOate (E), DETA NONOate (q), or DEA NONOate (OE) was present from the start of incubation (ϳ20 s before mitochondria). Ca 2ϩ was added at 2 min, and the maximum swelling rate achieved within 20 min was recorded. NO ⅐ release rates were calculated as detailed under "Experimental Procedures." Data are means Ϯ S.E. from at least five independent experiments.
FIG. 2. The effects of NO ⅐ on mitochondrial Ca
2؉ accumulation and membrane potential. A, mitochondria were incubated at 0.25 mg of protein/ml in the presence of Arsenazo III (100 M). After 30 s, CaCl 2 (10 M) was added as indicated by the arrow, followed by FCCP (1 M) and then EGTA (1 mM) as indicated. Traces are annotated as follows. Control, additions as detailed above; Ru Red, in the presence of ruthenium red (10 M); NO, in the presence of spermine NONOate (1.1 mM) from the start of the incubation (ϳ20 s before mitochondria). Data are representative of a larger experimental population (n ϭ 3). B, mitochondria were incubated at 1 mg of protein/ml in conditions identical to those in Fig. 1 , except for the presence of nigericin (100 nM). Membrane potential (⌬) was measured using an electrode sensitive to TPMP ϩ , whereby a decrease in the TPMP ϩ signal indicates development of a ⌬. TPMP ϩ additions (1 M each) were made as indicated by the arrows (T), followed by succinate (5 mM) and FCCP (1 M) as indicated. Data are representative of a larger experimental population (n ϭ 3).
between PTP and cytochrome c release, the effect of adding NO ⅐ at different times during swelling was examined. Fig. 5B shows that the addition of spermine NONOate before mitochondria or at the same time as Ca 2ϩ inhibited the PTP, whereas the addition on the verge of the rapid phase of swelling was ineffective. A partial inhibition of swelling resulted if NO ⅐ was added 2 min after Ca 2ϩ , at a point after which essentially all cytochrome c had been released (Fig. 5A) . This is confirmed in the inset to Fig. 5B , which shows the effect of time of the addition of NO ⅐ on cytochrome c release.
The relationship between the degree of swelling and cytochrome c release in the presence and absence of NO ⅐ is shown in Fig. 6 . These data again demonstrate that in the absence of NO ⅐ most cytochrome c release occurs with only moderate (25%) swelling. However, when NO ⅐ partially inhibits the PTP, this relationship is modified such that a much greater degree of swelling (ϳ80%) is required to elicit substantial release of cytochrome c.
DISCUSSION
Release of mitochondrial cytochrome c to the cytosol through mechanisms related to opening of the PTP has been intensively investigated. It is well recognized that the PTP can play a central role in apoptosis (27, 28, 33, 35) and that NO ⅐ has specific interactions with mitochondria at the level of both cytochrome c oxidase and complex III (13-15, 39 ). Since it is also known that NO ⅐ can modulate apoptosis, it was hypothesized that the mechanism may be operative at the level of the mitochondrial PTP and cytochrome c release. However, the literature is far from clear on the basic elements of this hypothesis, including an examination of the effects of NO ⅐ release rate on the PTP and the temporal relationship between cytochrome c release and PTP opening. This is important, since in a cellular setting gradients of NO ⅐ and varying rates and sites of formation are likely to result in partial modulatory effects on mitochondrial function. These issues were addressed in isolated mitochondria using biologically relevant rates of NO ⅐ formation, and effects on PTP and cytochrome c release were determined.
When administered at the start of incubations (ϳ20 s before mitochondria), NO ⅐ was able to inhibit PTP opening at rates of NO ⅐ release compatible with the physiologic range achievable by NO ⅐ synthases (Fig. 1) (46) . This suggests that the PTP may be a target for the antiapoptotic effects of physiological levels of NO ⅐ . At high release rates (Ͼ2 M/s), NO ⅐ restored PTP opening to control levels and, in agreement with a previous study (36) , shortened the delay to the onset of PTP following the Ca 2ϩ addition (not shown). However, such concentrations of NO ⅐ are in excess of those expected to be encountered in vivo, even under pathologic conditions with maximal stimulation of iNOS (46) . It is likely that at such high concentrations NO ⅐ may form S-nitrosating species or react with superoxide to form ONOO Ϫ (25) . Both of these reactive nitrogen species have been shown to induce PTP opening when added to Ca 2ϩ -loaded mitochondria (37, 38) , and ONOO Ϫ is capable of inducing apoptosis (22) (23) (24) . To elucidate which stage of the PTP was inhibited by NO ⅐ , experiments were performed in which NO ⅐ was added at different time points after the addition of Ca 2ϩ . Fig. 5B shows that the time of the NO ⅐ addition to mitochondria is critical in determining its effects on the PTP. The requirement for the presence of NO ⅐ within 1-2 min after the initiation of Ca 2ϩ -induced swelling (traces B-D) suggests that NO ⅐ is exerting its effects at an early stage in PTP development such as Ca 2ϩ entry into the mitochondrial matrix. Fig. 2 shows that NO ⅐ does indeed inhibit the ability of mitochondria to accumulate Ca 2ϩ , and consistent with the literature (40) the likely mechanism is by inhibiting the development of a membrane potential upon substrate addition to mitochondria. Consistent with Ca 2ϩ accumulation as a target for the inhibitory effects of NO ⅐ on the PTP, Fig. 3B shows that NO ⅐ inhibits t-BuOOH-dependent PTP opening, which is also Ca 2ϩ -dependent. In addition, NO ⅐ inhibited Ca 2ϩ plus phosphate-induced PTP. Together these data support the hypothesis that NO ⅐ inhibits the PTP by inhibiting membrane potential-driven Ca 2ϩ accumulation. The addition of oxyHb to bind NO ⅐ completely reverses its effects on PTP opening (Fig. 3A) . These data indicate that NO ⅐ may be decreasing mitochondrial membrane potential through reversible inhibition of electron transport, possibly by binding to heme groups such as those in cytochrome c oxidase (13) or complex III (39) . The binding of NO ⅐ to cytochrome c oxidase is competitive with oxygen (13), and thus if this enzyme is the molecular target for NO ⅐ inhibition of the PTP, the concentrations of NO ⅐ required to inhibit PTP opening at physiological oxygen tensions (1-5 M) would be much lower than those observed here (at saturating, 240 M O 2 ).
The release of apoptogenic proteins including cytochrome c from mitochondria is mechanistically linked to PTP opening. In agreement with this, Fig. 4 shows that inhibition of the PTP by NO ⅐ also inhibits cytochrome c release. This suggests that the PTP may be a target for the antiapoptotic effects of NO ⅐ . In a cytoprotective role, complete inhibition of PTP opening by NO ⅐ is unlikely and would be detrimental through inhibition of ATP synthesis (16, 17) . In order to more precisely understand the cytoprotective role of NO ⅐ , a series of experiments were performed to determine the temporal relationship between PTP opening and cytochrome c release and the effects of varying rates of NO ⅐ on these parameters.
Cytochrome c release is an early event in PTP opening, and consistent with this observation, the addition of NO ⅐ to mitochondria 2 min after Ca 2ϩ is moderately effective at preventing swelling but completely ineffective at inhibiting cytochrome c release (Fig. 5, B and inset) . In the absence of NO ⅐ , the relationship between cytochrome c release and swelling is hyperbolic in character, such that very little swelling is required for almost complete cytochrome c release. This result may partly explain some observations that cytochrome c release can occur in cells without appreciable signs of PTP opening (47) . In the presence of NO ⅐ , the curve in Fig. 6 is shifted significantly to the right, indicating that a far greater degree of swelling is required to elicit cytochrome c release. This has significant implications for the role of NO ⅐ in apoptosis and suggests that acute control of cytochrome c release is an antiapoptotic target for NO ⅐ .
In summary, we have identified inhibition of mitochondrial PTP opening as a novel site of action for NO ⅐ signaling in apoptosis. The mechanism involves depolarization of the mitochondrial membrane and inhibition of Ca 2ϩ accumulation. Clearly, in the cellular setting the effects of NO ⅐ on mitochondrial function are not expected to result in complete inhibition (Fig. 5B) , cytochrome c release and degree of swelling were calculated and expressed as percentages of the maximum that day. All data are means Ϯ S.E. of at least four independent experiments (*, p Ͻ 0.1; **, p Ͻ 0.05 between corresponding points on control and NO ⅐ -inhibited curves).
of respiration but favor partial inhibition of mitochondria. In turn, it is postulated that this would result in NO ⅐ lowering the concentration of cytochrome c available to initiate apoptosis. These experiments suggest that a fine balance exists between the pro-and antiapoptotic properties of NO ⅐ at the level of the mitochondrion.
